Conavi Medical Corp.
CNVI.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 93.50K | 156.40K | 266.50K | 45.50K | 40.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.50K | 156.40K | 266.50K | 45.50K | 40.40K |
| Cost of Revenue | -- | -- | 24.00K | 700.00 | -60.60K |
| Gross Profit | 93.50K | 156.40K | 242.50K | 44.80K | 101.00K |
| SG&A Expenses | 1.57M | 1.75M | 1.18M | 925.10K | 1.06M |
| Depreciation & Amortization | 130.20K | 133.40K | 145.20K | 146.70K | 140.10K |
| Other Operating Expenses | -24.40K | 255.40K | 11.60K | -- | -- |
| Total Operating Expenses | 3.39M | 3.85M | 3.96M | 3.39M | 3.81M |
| Operating Income | -3.29M | -3.69M | -3.69M | -3.35M | -3.77M |
| Income Before Tax | -3.44M | -1.94M | -4.93M | -2.57M | -2.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.44M | -1.94M | -4.93M | -2.57M | -2.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.44M | -1.94M | -4.93M | -2.57M | -2.18M |
| EBIT | -3.29M | -3.69M | -3.69M | -3.35M | -3.77M |
| EBITDA | -3.21M | -3.61M | -3.60M | -3.26M | -3.67M |
| EPS Basic | -0.03 | -0.03 | -0.06 | -0.04 | -0.05 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.04 | -0.02 | -0.03 |
| EPS Diluted | -0.03 | -0.03 | -0.06 | -0.04 | -0.05 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.04 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 99.89M | 76.75M | 77.19M | 68.54M | 44.25M |
| Average Diluted Shares Outstanding | 99.89M | 76.75M | 77.19M | 68.54M | 44.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |